Latest Content

DSCV ELCO EOG IOG QXT SRT TWD
Morning Note – 29 July 2021


 View

  • 29 Jul 21
  • -
  • -
SRT Marine Systems plc
SRT Marine Systems - Systems business expected to flow again in FY22

The FY Mar21 results are as flagged in the April trading update; clearly it is disappointing that COVID delayed revenues from the Systems business this year (both revenue milestones in the Philippines and revenue from signing new contracts) leaving just Transceiver sales. However the global need and demand for MDA has not gone away; activity in this business has been pent-up and will recommence as COVID restrictions are eased this year. Meanwhile SRT has used the Systems delay well, catching up

 View

  • 29 Jul 21
  • -
  • -
Trackwise Designs Plc
Trackwise Designs - H1 update shows good progress – FY in line with expectations

The trading update confirms H2 trading and the FY outlook is in line with expectations, with a good first-half performance and significant investment in new facilities and capabilities. Revenue growth was constrained by continuing pandemic, supply chain and Brexit effects, though with some recent signs of improvement. IHT opportunities are progressing well, including with its EV OEM, with APCBs seeing solid growth but with an increase in demand and order book, it plans to introduce a second shif

 View

  • 29 Jul 21
  • -
  • -
discoverIE Group PLC
discoverIE - Clear growth strategy, record order book, further upgrades

In a positive Q1 trading update discoverIE has confirmed that the strong order growth reported in H2 2021 has continued. The order book at June 2021 was £220m, 50% higher organically than last year and 30% higher organically than two years ago. Q1 was ahead of the Board’s expectations with sales +21% ahead of Q1 2021 at CER (+16% yoy organically and +10% organically compared with two years ago). By region, China and Germany have produced the strongest growth. Organic growth was similar in both d

 View

  • 29 Jul 21
  • -
  • -
ANGLE plc
ANGLE - Pharma services contract with new customer

ANGLE announced its second pharma services contract with an undisclosed drug development company, using Parsortix firstly to develop two custom CTC assays to look at biomarkers of DNA damage repair, for which it will be paid c.$0.4m and, secondly, if successful, to use these validated assays for longitudinal analysis in a subsequent clinical trial planned to start in H2 2022. The revenue from the first phase of the contract is expected to be recognised over a 12-month period. ANGLE also confirme

 View

  • 28 Jul 21
  • -
  • -
PEB QTX TRCS TRI
Morning Note – 28 July 2021


 View

  • 28 Jul 21
  • -
  • -
 

finnCap Research and Daily Commentaries

Research Tree offers finnCap research, providing ongoing coverage of 307 shares , as well as macro-economic categories including: Commodities - Metals & Mining. We offer 3588 reports from finnCap on Research Tree.

  • Research reports provided by finnCap

  • Companies covered by finnCap

  • Sectors covered by finnCap


Related Content

View the latest research on other companies in the sector. 

Morning Note – 24 November 2020

Intercede (IGP): Corp | Trifast (TRI): Corp

Intercede Group plc Trifast plc

  • 24 Nov 20
  • -
Morning Note – 23 November 2020

Avacta (AVCT): Corp | Evgen Pharma (EVG): Corp

Avacta Group PLC Evgen Pharma Plc

  • 23 Nov 20
  • -
Morning Note – 12 November 2020

Bango (BGO): Corp Microsoft deal will harness current Xbox demand | Ideagen (IDEA): Corp Comfortable interim trading update | LPA Group (LPA): Corp Year-end trading update | Redcentric (RCN): Corp That which does not kill you makes you stronger

IDEA RCN LPA BGO

  • 12 Nov 20
  • -
Morning Note – 10 November 2020

Destiny Pharma (DEST): Corp

Destiny Pharma Plc

  • 10 Nov 20
  • -
Morning Note – 9 November 2020

K3 Capital (K3C): Corp

K3 Capital Group Plc

  • 09 Nov 20
  • -
Morning Note – 3 November 2020

Cora Gold (CORA): Corp | Independent Oil & Gas (IOG): Corp | Touchstone Exploration (TXP): Corp

IOG TXP CORA

  • 03 Nov 20
  • -